{"collection_id":"acrin_6698","collection_name":"ACRIN-6698","cancer_types":"Breast Cancer","tumor_locations":"Breast","species":"Human","subjects":385,"supporting_data":"Clinical, Image Analyses","description":"The American College of Radiology Imaging Network (ACRIN) trial 6698 was a multi-center study to\nevaluate the effectiveness of quantitative diffusion weighted imaging (DWI) for assessing breast\ncancer response to neoadjuvant chemotherapy (NAC). ACRIN 6698 was performed as a sub-study of the\nongoing I-SPY 2 TRIAL (Investigation of Serial studies to Predict Your Therapeutic Response with\nImaging And moLecular Analysis 2), an adaptive, multi-agent phase II trial designed to quickly\nidentify new agents for breast cancer.\nPlease see the ACRIN 6698/I-SPY2 Breast DWI (https://doi.org/10.7937/TCIA.KK02-6D95) wiki page to\nlearn more about the images and to obtain any supporting metadata for this collection.","patients":385,"studies":1123,"series":18747,"instances":2911334,"size_TB":0.842,"modalities":["MR","SEG"],"licenses":[{"license_short_name":"CC BY 4.0","series":18747,"size_TB":0.842}]}